Order Article Reprints

Correia JS, Neves-Carvalho A, Mendes-Pinheiro B, Pires J, Teixeira FG, Lima R, Monteiro S, Silva NA, Soares-Cunha C, Serra SC, et al. Preclinical Assessment of Mesenchymal-Stem-Cell-Based Therapies in Spinocerebellar Ataxia Type 3. Biomedicines. 2021; 9(12):1754. https://doi.org/10.3390/biomedicines9121754

Correia, Joana Sofia, Andreia Neves-Carvalho, Bárbara Mendes-Pinheiro, Joel Pires, Fábio Gabriel Teixeira, Rui Lima, Susana Monteiro, Nuno André Silva, Carina Soares-Cunha, Sofia Cravino Serra, and et al. 2021. "Preclinical Assessment of Mesenchymal-Stem-Cell-Based Therapies in Spinocerebellar Ataxia Type 3" Biomedicines 9, no. 12: 1754. https://doi.org/10.3390/biomedicines9121754

Correia, J. S., Neves-Carvalho, A., Mendes-Pinheiro, B., Pires, J., Teixeira, F. G., Lima, R., Monteiro, S., Silva, N. A., Soares-Cunha, C., Serra, S. C., Duarte-Silva, S., Teixeira-Castro, A., Salgado, A. J., & Maciel, P. (2021). Preclinical Assessment of Mesenchymal-Stem-Cell-Based Therapies in Spinocerebellar Ataxia Type 3. Biomedicines, 9(12), 1754. https://doi.org/10.3390/biomedicines9121754